Skip to main content
SpringerLink
Log in

Staging and Treatment. II-1. Staging and Prognosis

  • Chapter
  • First Online:
Gastrointestinal Cancer

  • 384 Accesses

Abstract

Cancer of the anal region is relatively rare in gastrointestinal tract malignancy. However, the worldwide incidence of anal cancer has increased [1, 2]. Because current guidelines do not recommend surgical treatment as a first therapeutic option, the staging of anal cancer is based on clinical staging by physical examination and radiological imaging. In this chapter, we will discuss the diagnostic workup, staging, and prognosis of anal cancer.

Hyeon Jeong Goong is the lead author of this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Islami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A. International trends in anal cancer incidence rates. Int J Epidemiol. 2017;46:924–38.

    PubMed  Google Scholar 

  2. Park HC, Jung KW, Kim BW, Shin A, Won YJ, Oh JH, et al. Characteristics and survival of Korean anal cancer from the Korea central cancer registry data. Ann Coloproctol. 2013;29:182–5.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Rao S, Guren MG, Khan K, Brown G, Renehan AG, Steigen SE, et al. Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32:1087–100.

    Article  CAS  PubMed  Google Scholar 

  4. Caldarella C, Annunziata S, Treglia G, Sadeghi R, Ayati N, Giovanella L. Diagnostic performance of positron emission tomography/computed tomography using fluorine-18 fluorodeoxyglucose in detecting locoregional nodal involvement in patients with anal canal cancer: a systematic review and meta-analysis. ScientificWorldJournal. 2014;2014:196068.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mahmud A, Poon R, Jonker D. PET imaging in anal canal cancer: a systematic review and meta-analysis. Br J Radiol. 2017;90:20170370.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bhuva NJ, Glynne-Jones R, Sonoda L, Wong WL, Harrison MK. To PET or not to PET? That is the question. Staging in anal cancer. Ann Oncol. 2012;23:2078–82.

    Article  CAS  PubMed  Google Scholar 

  7. Jones M, Hruby G, Solomon M, Rutherford N, Martin J. The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2015;22:3574–81.

    Article  PubMed  Google Scholar 

  8. Albertsson P, Alverbratt C, Liljegren A, Bjorkander E, Strandell A, Samuelsson O, et al. Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2018;126:6–12.

    Article  PubMed  Google Scholar 

  9. Welton ML, Steele SR, Goodman KA, et al. Anus. In: Amin MB, editor. AJCC cancer staging manual. 8th ed.: Springer; 2017.

    Google Scholar 

  10. Anonymous. SEER cancer stat facts: anal cancer. 2019. https://seer.cancer.gov/statfacts/html/anus.html.

  11. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

    Article  PubMed  Google Scholar 

  12. Hur H, Jung K-W, Kim B-W, Oh C-M, Won Y-J, Oh JH, et al. Long-term oncologic outcome and its relevant factors in anal cancer in Korea: a nationwide data analysis. Ann Coloproctol. 2020;36:35–40.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040–9.

    Article  CAS  PubMed  Google Scholar 

  14. Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, et al. Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11). Cancer. 2010;116:4007–13.

    Article  PubMed  Google Scholar 

  15. Glynne-Jones R, Sebag-Montefiore D, Adams R, Gollins S, Harrison M, Meadows HM, et al. Prognostic factors for recurrence and survival in anal cancer. Cancer. 2013;119:748–55.

    Article  CAS  PubMed  Google Scholar 

  16. Bilimoria KY, Bentrem DJ, Rock CE, Stewart AK, Ko CY, Halverson A. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base. Dis Colon Rectum. 2009;52:624–31.

    Article  PubMed  Google Scholar 

  17. Serup-Hansen E, Linnemann D, Skovrider-Ruminski W, Høgdall E, Geertsen PF, Havsteen H. Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on cancer stages I to III carcinoma of the anal canal. J Clin Oncol. 2014;32:1812–7.

    Article  PubMed  Google Scholar 

  18. Urbute A, Rasmussen CL, Belmonte F, Obermueller T, Prigge E-S, Arbyn M, et al. Prognostic significance of HPV DNA and p16INK4a in anal cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2020;29:703.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea (Republic of)

    Hoon Jai Chun

  2. Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea (Republic of)

    Seun Ja Park

  3. Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Kyonggi-do, Korea (Republic of)

    Yun Jeong Lim

  4. Department of Internal Medicine, Yonsei University Severance Hospital, Seoul, Korea (Republic of)

    Si Young Song

Authors
  1. Hoon Jai Chun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seun Ja Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yun Jeong Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Si Young Song
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chun, H.J., Park, S.J., Lim, Y.J., Song, S.Y. (2023). Staging and Treatment. II-1. Staging and Prognosis. In: Gastrointestinal Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-99-0815-8_43

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-0815-8_43

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-0814-1

  • Online ISBN: 978-981-99-0815-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation